The below Parliamentary question was asked by Danny Kinahan on 2015-12-14.
To ask the Secretary of State for Health, if he will place greater emphasis on improving cancer diagnosis rates when forming his Department’s policies in future.
Jane Ellison
Improving early diagnosis of cancer is a priority for this Government. We will continue to work with NHS England, Public Health England and other partners to achieve early diagnosis through improved screening programmes, Be Clear on Cancer campaigns to raise awareness of symptoms of cancer to encourage people with symptoms to present promptly to their general practitioner (GP), and help for GPs to refer more accurately.
We have committed to implementing recommendation 24 of the Independent Cancer Taskforce’s report Achieving World-Class Outcomes that by 2020, everyone referred with a suspicion of cancer will receive either a definitive diagnosis or the all-clear within four weeks. NHS England is working with partners across the health system to consider how best to take this forward. This standard will be underpinned by investment of up to £300 million more in diagnostics each year by 2020.
NHS England has launched a major early diagnosis programme, Accelerate, Co-ordinate, Evaluate (ACE), working jointly with Cancer Research UK and Macmillan Cancer Support to test new innovative approaches to identifying cancer more quickly. Outputs from the first wave of test sites, which commenced in April 2015, will be delivered on a phased basis, with the majority falling between September 2015 and December 2016. It is expected that ACE Wave 1 evaluation will be complete by mid-2017.
In June this year, the National Institute for Health and Care Excellence published an updated guideline ‘Suspected cancer: recognition and referral’. The guideline focuses on key symptoms, to make it easier to use and will continue to support GPs to identify patients with symptoms of suspected cancer, and urgently refer them as appropriate. The guideline recommends a lower referral threshold for urgent referrals where cancer is suspected.
